Trupanion, Inc. (NASDAQ:TRUP) Given Average Recommendation of “Hold” by Brokerages

Trupanion, Inc. (NASDAQ:TRUP) has earned an average rating of “Hold” from the six ratings firms that are covering the company, Marketbeat reports. One analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and two have given a buy recommendation to the company. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year is $42.25.

A number of research analysts have recently weighed in on the stock. Cantor Fitzgerald cut their price target on shares of Trupanion from $42.00 to $34.00 and set a “neutral” rating on the stock in a report on Thursday, April 9th. Piper Sandler cut their price target on shares of Trupanion from $60.00 to $45.00 and set an “overweight” rating on the stock in a report on Friday, February 13th. Weiss Ratings downgraded shares of Trupanion from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, March 4th. Zacks Research downgraded shares of Trupanion from a “strong-buy” rating to a “hold” rating in a report on Friday, February 13th. Finally, Bank of America cut their price target on shares of Trupanion from $63.00 to $59.00 and set a “buy” rating on the stock in a report on Tuesday, April 14th.

Insider Activity

In related news, COO John R. Gallagher sold 5,283 shares of Trupanion stock in a transaction on Friday, February 27th. The shares were sold at an average price of $26.52, for a total value of $140,105.16. Following the transaction, the chief operating officer owned 32,387 shares in the company, valued at $858,903.24. This trade represents a 14.02% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Fawwad Qureshi sold 4,645 shares of Trupanion stock in a transaction on Wednesday, February 25th. The stock was sold at an average price of $25.61, for a total transaction of $118,958.45. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 21,503 shares of company stock worth $578,537. 5.42% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. Federated Hermes Inc. bought a new position in Trupanion in the 3rd quarter worth $33,000. Pilgrim Partners Asia Pte Ltd bought a new position in Trupanion in the 3rd quarter worth $39,000. Kemnay Advisory Services Inc. bought a new position in Trupanion in the 4th quarter worth $64,000. Kelleher Financial Advisors bought a new position in Trupanion in the 3rd quarter worth $74,000. Finally, PNC Financial Services Group Inc. raised its holdings in Trupanion by 21.7% in the 3rd quarter. PNC Financial Services Group Inc. now owns 2,678 shares of the financial services provider’s stock worth $116,000 after acquiring an additional 478 shares during the period.

Trupanion Trading Down 3.8%

Shares of NASDAQ:TRUP opened at $24.92 on Friday. The firm has a fifty day moving average of $26.21 and a two-hundred day moving average of $32.58. The firm has a market capitalization of $1.09 billion, a P/E ratio of 42.24 and a beta of 1.49. Trupanion has a 12-month low of $23.80 and a 12-month high of $57.88. The company has a quick ratio of 1.73, a current ratio of 1.73 and a debt-to-equity ratio of 0.25.

Trupanion (NASDAQ:TRUP) last released its quarterly earnings results on Thursday, April 30th. The financial services provider reported $0.11 earnings per share for the quarter, beating analysts’ consensus estimates of $0.07 by $0.04. The business had revenue of $384.05 million for the quarter, compared to the consensus estimate of $379.77 million. Trupanion had a net margin of 1.74% and a return on equity of 6.87%. Trupanion’s revenue for the quarter was up 12.3% on a year-over-year basis. During the same quarter last year, the firm earned ($0.03) EPS. On average, equities analysts expect that Trupanion will post 0.51 EPS for the current fiscal year.

About Trupanion

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.